Regulatory approval is next: Mizuho lifts Biogen to buy on news of Alzheimer’s drug success
Next stop regulatory approval. That was the view of analysts at Mizuho Securities, who late…
Read MoreNext stop regulatory approval. That was the view of analysts at Mizuho Securities, who late…
Read MoreEisai Co. shares were indicated sharply higher Wednesday morning after the Japanese drug maker and…
Read MoreApple Inc. is dropping plans to boost production of its latest iPhones this year after…
Read MoreApple Inc. is dropping plans to boost production of its latest iPhones this year after…
Read MoreEisai Co. 4523, +0.89% and Biogen Inc. BIIB, +1.04% said their experimental Alzheimer’s disease drug…
Read MoreIntel Corp. disagrees with Nvidia Corp. when it comes to Moore’s Law as Intel Chief…
Read MoreTrading app Robinhood Markets Inc. has finally rolled out a noncustodial crypto wallet to 10,000…
Read MoreThe successful collision of a NASA spacecraft with an asteroid lifted space sector stocks before…
Read MoreThe successful collision of a NASA spacecraft with an asteroid lifted space sector stocks before…
Read MoreThe federal government could require new cars to have anti-drunk-driving systems within three years. A…
Read More